(Q40513840)

21 September 2017

title

Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism (English)

1 reference

21 September 2017

0 references

1 reference

Juan C Mayo

2

0 references

Rosa María Sainz

object named as

Rosa M Sainz

series ordinal

1

0 references

Russel J Reiter

series ordinal

6

object named as

Russel J Reiter

1 reference

21 September 2017

5

Lucien Manchester

1 reference

21 September 2017

Dun-xian Tan

3

1 reference

21 September 2017

Josefa León

series ordinal

4

1 reference

21 September 2017

publication date

1 April 2005

1 reference

21 September 2017

1 reference

21 September 2017

volume

63

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

29-43

1 reference

Neuroendocrine differentiation in prostatic carcinoma

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Chemotherapy for advanced hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Melatonin, longevity and health in the aged: an assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Hormonal interactions in human prostate tumor LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Melatonin inhibits nitrate tolerance in isolated coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Melatonin receptors and their regulation: biochemical and structural mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Antioxidant activity of melatonin in Chinese hamster ovarian cells: changes in cellular proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

The chemistry of melatonin's interaction with reactive species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Melatonin induction of filamentous structures in non-neuronal cells that is dependent on expression of the human mt1 melatonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1α,24‐dihydroxyvitamin D2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Dual effect of pituitary adenylate cyclase activating polypeptide on prostate tumor LNCaP cells: short- and long-term exposure affect proliferation and neuroendocrine differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20155

21 January 2018

Identifiers

DOI

10.1002/PROS.20155

1 reference

21 September 2017

1 reference